Harrison.ai was featured in the Sky News 2600 newsletter

Updated: Aug 22, 2019

The development of IVY with Harrison.ai has been an exciting project which we believe will make a significant contribution to patient care and outcomes,” says Sue Channon, Group CEO, Virtus Health. “We believe IVY is the most advanced tool of its kind in human embryology. Artificial intelligence technology is likely, in the future, to be the dominant embryo selection method used in IVF.”

Link



Recent Posts

See All
Subscribe to our newsletter

Privacy  |  Terms of Use  |   © 2019 Harrison-AI Pty Ltd. All rights reserved.